John Pakulski

John Pakulski is an experienced regulatory affairs and clinical development professional currently serving as the Senior Vice President of Regulatory Affairs & Clinical Development at Kashiv BioSciences LLC since January 2019 and as Senior Vice President of Global Regulatory Affairs at Prolong Pharmaceuticals since March 2021. Prior to these roles, John Pakulski operated as a Regulatory Affairs and Drug Development Consultant at John Pakulski Consulting for a brief period in 2018. John Pakulski has also held significant positions at Mylan as Head of Global Regulatory Science, Biologics, and at Sandoz Pharmaceuticals as Head of US Biopharmaceutical Regulatory Affairs, with a focus on biosimilars. Educational credentials include studies at Rutgers University, College of Pharmacy.